Omnicell Inc Investor and Analyst Day at the Annual ASHP Midyear Meeting Transcript
Good morning, everyone. Welcome to the Omnicell Investor and Analyst Day at the ASHP mid-year with you. It's good to see everyone in the room. So welcome to the
(technical difficulty)
this morning will include forward-looking statements
(technical difficulty)
this meeting is also webcast live. We will post a recording of today's webcast and a copy of the presentation in the Investor Relation section of our website at omnicell.com.
Let's now move to our agenda. Agenda for today is as follows: first, Randall Lipps, Omnicell's Chairmen, President, CEO and Founder, will give an update on our mission and discuss our purpose, strategy and priorities; next, Scott Seidelmann, Omnicell's Chief Commercial Officer, will discuss interface and medication management and the 3 areas of growth, starting with point-of-care and opportunities we're seeing in central pharmacy. It's how our customers drive better outcomes, fee automation, analytics and services. This is followed by a note for you, of the Autonomous
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |